seen from United States
seen from United States
seen from United States
seen from United States
seen from United Kingdom
seen from United States
seen from United States
seen from China
seen from China
seen from China
seen from Malaysia
seen from Maldives
seen from United States
seen from India
seen from Malaysia
seen from Yemen
seen from Namibia
seen from United Kingdom
seen from Australia
seen from China
Pergolide has been the mainstay treatment of Equine Cushing’s disease, also known as pituitary pars intermedia dysfunction, for several de
"Effective Dec. 1, horses that are granted a therapeutic use exemption for pergolide can remain on pergolide with no withdrawal of drug prior to competition and no need to file a medication report form each time they compete."
